|
Volumn 35, Issue 1, 2010, Pages 93-94
|
Comparative in vitro activity of oritavancin against recent, genetically diverse, community-associated meticillin-resistant Staphylococcus aureus (MRSA) isolates
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIPROFLOXACIN;
DAPTOMYCIN;
ERYTHROMYCIN;
LINEZOLID;
METICILLIN;
ORITAVANCIN;
OXACILLIN;
PANTON VALENTINE LEUKOCIDIN;
POLYSORBATE 80;
STAPHYLOCOCCUS PROTEIN A;
TEICOPLANIN;
VANCOMYCIN;
WATER;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL ACTIVITY;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
BROTH DILUTION;
CONTROLLED STUDY;
GENE CASSETTE;
GENETIC MARKER;
GENETIC VARIABILITY;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
IN VITRO STUDY;
LETTER;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
ANTI-BACTERIAL AGENTS;
BACTERIAL TYPING TECHNIQUES;
COMMUNITY-ACQUIRED INFECTIONS;
GENES, BACTERIAL;
GENETIC VARIATION;
GENOTYPE;
GLYCOPEPTIDES;
HUMANS;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TESTS;
STAPHYLOCOCCAL INFECTIONS;
|
EID: 70849120361
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2009.07.012 Document Type: Letter |
Times cited : (7)
|
References (7)
|